1. Home
  2. SAVA vs MIND Comparison

SAVA vs MIND Comparison

Compare SAVA & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.29

Market Cap

103.9M

Sector

Health Care

ML Signal

HOLD

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$9.50

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
MIND
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
103.9M
83.4M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
SAVA
MIND
Price
$2.29
$9.50
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
863.6K
200.5K
Earning Date
03-02-2026
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.38
Revenue
N/A
$46,195,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.08
P/E Ratio
N/A
$27.41
Revenue Growth
N/A
2.21
52 Week Low
$1.15
$4.45
52 Week High
$4.98
$14.50

Technical Indicators

Market Signals
Indicator
SAVA
MIND
Relative Strength Index (RSI) 48.84 48.15
Support Level $1.97 $7.90
Resistance Level $2.19 $10.94
Average True Range (ATR) 0.11 0.76
MACD 0.05 0.10
Stochastic Oscillator 85.14 46.42

Price Performance

Historical Comparison
SAVA
MIND

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: